RemeGen Co Ltd

Common Name
RemeGen
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
2,999
Ticker
688331
Exchange
SHANGHAI STOCK EXCHANGE
Description
RemeGen Co., Ltd. is a biotechnology company focusing on the research, development, and commercialization of novel biologics for the treatment of cancer, autoimmune disorders, and other serious diseas...

RemeGen's GHG Emissions Data Preview

In 2024, RemeGen completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, RemeGen has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind RemeGen’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore RemeGen’s data sources below and access millions more through our Disclosure Search.

a. RemeGen's ESG Report 2024
a. RemeGen's ESG Report 2024
b. RemeGen's ESG Report 2023
b. RemeGen's ESG Report 2023

Insights into RemeGen's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of RemeGen amounted to 59,153.38 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of RemeGen decreased by 15.73%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

RemeGen's Scope 1 Emissions Over Time

20212022202320240255075100tCO2e-43%
  • Total Scope 1
  • Year-over-Year Change

What are RemeGen's Scope 1 emissions?

In 2024, the total Scope 1 emissions of RemeGen were 54.15 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), RemeGen's Scope 1 emissions decreased by 43.46%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are RemeGen's Scope 2 emissions?

In 2024, RemeGen reported Scope 2 greenhouse gas (GHG) emissions of 59,099.23 tCO₂e without specifying the calculation method. a

Has RemeGen reduced its Scope 2 emissions over time?

Since 2021, RemeGen's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 166.42%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), RemeGen's Scope 2 emissions (Unspecified Calculation Method) fell by 15.69% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does RemeGen use for Scope 2 reporting?

In 2024, RemeGen reported its Scope 2 emissions using an unspecified methodology. a

RemeGen's Scope 2 Emissions Over Time

2021202220232024020 k40 k60 k80 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into RemeGen’s GHG Emissions Intensity Compared to Industry Peers

In 2024, RemeGen reported Scope 1 greenhouse gas (GHG) emissions of 54.15 tCO₂e and total revenues of USD 234 millions. This translates into an emissions intensity of 0.23 tCO₂e per millions USD. a

RemeGen's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$M

How does RemeGen's GHG emissions intensity compare to its peers?

In 2024, RemeGen reported a Scope 1 emissions intensity of 0.23 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does RemeGen rank on GHG emissions intensity within its industry?

In 2024, RemeGen ranked 5 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places RemeGen among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to RemeGen's GHG Emissions Dataset?
Sign Up